Page 4«..3456..1020..»

Womens Health: Stroke Awareness Month – WSYR

by: Sarah Darmanjian, Mary Wilson

ALBANY, N.Y. (NEWS10)- It may be surprising to hear that strokes kill twice as many women as breast cancer. In fact, one in five women between the ages of 55-75 will have a stroke, according to the Centers for Disease Control and Prevention (CDC).

Four out of five strokes can be prevented, making it important to know the risks and warning signs the CDC said.

80% of strokes are preventable and so the fact that we can prevent 80% of the strokes is really quite amazing, Dr. Alexandra Paul, a neurosurgeon at Albany Medical Center, told NEWS10s, Mary Wilson.

There are several reasons why women have a higher risk of stroke including pregnancy, birth control pills, migraine headaches, atrial fibrillation, high blood pressure and hypertension, said Dr. Paul.

The act of being pregnant actually puts women at a higher risk of having a stroke, oral contraceptives also increase the risk of stroke in women, he said.

High blood pressure or hypertension, is the most treatable cause of stroke. A healthy lifestyle is the best prevention, the CDC said.

Eat a healthy diet, maintain a healthy weight, be physically active, dont smoke, and have your blood pressure checked, Dr. Paul said.

Being able to identify the symptoms of a stroke can not only help yourself, it can also help your loved ones.

About 66% of the time, someone other than the stroke victim makes the decision to seek treatment and so recognizing the signs and sudden symptoms of stroke could actually help save a life, Dr. Paul said.

Source: Duke Health

The most common treatment for stroke victims is a clot-busting drug but it can only be given within four and a half hours after the onset of symptoms. Getting swift treatment can make a significant difference in a patients outcome.

Some stroke symptoms are reversible and thats called a transient ischemic attack and then some strokes are much more devastating where patients are left completely pelagic on one side, unable to move the arm or the leg and no speech at all, said Dr. Paul.

A thrombectomy can also lessen the debilitating effects of a stroke and can be done in a wider time frame.

We can go inside the blood vessels up to the blood vessels of the brain and try to take out the clot and that has had a really remarkable effect on reducing the disability of stroke in the country, Dr. Paul said.

The surgery is a newer treatment which can be done at Albany Medical Center but this isnt the case for all hospitals in America. One in six patients does not have access to a thrombectomy.

Originally posted here:
Womens Health: Stroke Awareness Month - WSYR

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

LETTER | Encouraging women in lower-income group to live healthy amidst pandemic – Malaysiakini

LETTER | Leave no one behind. That is our promise of the 2030 Agenda for Sustainable Development and Sustainable Development Goals and our government has been working hard to decrease the inequalities and vulnerabilities that leave people behind.

Unfortunately, we still have a significant number of people, mainly from the lower-income group, struggling to achieve socioeconomic and health equality. Socio-economic problems, and health and food insecurity are reported to be the main problems among the low-income group and amidst the pandemic, women and children, especially from the lower-income group who are the most negatively affected, require urgent attention.

Non-communicable diseases and malnutrition are some of the few health threats reported among women from the B40 group and these problems seem to be persistent among them. Studies have reported that the impact of diabetes is greater in females than in males with a worse outcome. Women with diabetes have a higher risk of heart diseases and earlier incidents of heart attack which can be fatal when compared to men.

Healthy habits are the most effective way to combat them, but, sadly, in the chaos of a woman's daily life, healthy living may take the back seat to chores, work, busy schedules, and more. To make matters worse, with the rising number of cases and the implementation of the movement control order again, these already vulnerable groups, are facing another period of social and economic uncertainties.

Why are we targetting women? Simply because women are responsible for producing and preparing food for their family and household; therefore, their knowledge or lack of it can create issues not only on womens own health but also on the health of the family members.

Ensuring the correct nutritional status is vital, especially now when we need our immune system to fight the disease.

Healthy habit is a combination of healthy eating, being physically active, avoiding smoking and limiting alcohol consumption. For more information, we suggest you see your physician and the dietitian. Some steps to overcome the barriers women face to live healthily include:

Adequate knowledge on healthy lifestyle is important for women not only because it helps them to be productive members of society but also because of the direct effect on their family members and the next generation.

Our low-income families are at risk of poor nutrition and unhealthy lifestyle with the ongoing lockdown; therefore, empowering and educating them can create an environment that benefits everyone.

Nothing must be done separately; make healthy choices for the whole family. In addition, do not be afraid to seek help if it is needed. This lockdown will leave some impact on our community and all these efforts will have a greater health impact if it comes from us ourselves.

DR KALAASHINI RAMACHANDRAN is with the Department of Public Health University of Malaya Medical Council and DR HAZREEN ABDUL MAJID isHead of Centre for Population Health, Department of Social and Preventive Medicine, Universiti Malaya.

The views expressed here are those of the author/contributor and do not necessarily represent the views of Malaysiakini.

Go here to see the original:
LETTER | Encouraging women in lower-income group to live healthy amidst pandemic - Malaysiakini

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Forum, May 28: Elected leaders should follow the science on mask-wearing – Valley News

Elected leaders should follow the science on mask-wearing

Recent bursts of sunshine, nearly cloudless skies and summer-like temperatures have got us all outside, recovering not only from the long New Hampshire winter but also from the isolation of COVID-19. It also has us wondering when we might be able to give up the masks weve worn for the past year. Local elected officials are holding public hearings, soliciting input from citizens on mask mandates. Its a controversial issue, with strong feelings on both sides.

Now is the time for strong leadership.

As elected officials, I believe we have to follow the science. This will help us with our fear. There are objective facts out there, and it is our duty to pursue them. Monica Gandhi, professor of medicine and director of AIDS research at the University of California at San Francisco, who was a strong proponent of masking, is now strongly suggesting that we take them off.

In a recent PBS interview, she draws from the Centers for Disease Control and Prevention, as well as such publications as JAMA, to update us on the research. What might appear as a sudden reversal of opinion regarding mask-wearing, she explains, is not.

Study after study has shown the effectiveness of the vaccines. They are even more effective than originally thought. The vaccines, she further explains, also block transmission.

Additionally, she worries about decreasing the strength of our immune systems through continued mask-wearing. Humans simply need exposure to some pathogens in order to remain strong. (Remember our worries, eons ago, about overuse of antibacterial cleanser on our hands that it might lessen our immunity? That was a solid worry, it turns out.)

Finally and Im drawing directly from Dr. Gandhi here we should remember to be grateful. We live in the richest country in the world: The vaccines were developed in record time, and they have been dispensed with record speed. For those of us who have traveled in developing countries, we can be grateful for the resources that we have at our disposal.

I hope that this means we can be happy, and hopeful.

WENDY PIPER

Enfield

The writer is chair of the Grafton County Commissioners.

Forum contributor Margaret D. Hurley describes the cruelty to animals and the damage to our health and the health of the planet by the consumption of meat and dairy (Stop normalizing animal cruelty, May 25). She seems to be despairing of the Valley News ignoring this kind of news. But I see the printing of her letter as a sign of validation of the subject.

I believe many of us are aware of the cruelty of factory-farmed livestock. Those methods torture and exploit animals and yet, unfortunately, continue to flourish. Maybe this is due to conditioning, habit and the advertising and marketing practices of the meat and dairy industries.

Just eliminating the consumption of factory-farmed animals may not satisfy those opposed to it, but it would be a step in the right direction of living a more compassionate and healthy lifestyle.

As to our own health, studies such as Colin Campbells The China Study point to a whole-food, plant-based diet as a healthy food choice. Yet we seem to be on our own as far as learning how to go about this. I guess many health care practitioners may not feel adequately trained to include that in their wellness programs. Luckily, there are helpful resources, such as foodrevolution.org, run by John and Ocean Robbins.

To the list of documentaries on the subject of plant-based diet, a good one to add is The Game Changers. This may especially appeal to sports-oriented folks. It is gripping and convincing and may begin the process of change, namely starting with compassion for our own bodies.

Self-compassion may be a good entrance point to this ever-evolving journey of a step-by step move toward a more sustainable and compassionate future. When we learn to take care of ourselves we can really thrive and be as healthy as possible.

It may automatically lead to compassion for animals, our co-inhabitants, and to the healing of our beautiful but severely overtaxed natural world.

BINEKE PEL OORT

Wilder

My maternal grandfathers birth surname was Yerushalimsky, a Europeanized version of Yerushalmi, which means of or from Jerusalem. That itself means nothing, of course, but my grandfather was a kohen, or hereditary member of the priestly caste, and careful attribution of that lineage is taken quite seriously in Judaism. Performance of every ritual for significant life events depends on it. And my father was a hereditary member of the priestly assistants class, ditto and likewise. (Imagine the shonda when I became a Muslim and remained so for a considerable number of years!)

U.S. Rep. Rashida Tlaibs maiden name was Harbi, which means of or from the tribe of Harb, originating in the southern part of the Arabian peninsula. (Of course, if you boil us down, Im just a Brooklynite and shes a Detroiter.

But funny thing: A handful of my cousins were born in Mandatory Palestine, and therefore were legally of Palestinian citizenship, according to the governing British law of the time, before they acquired Israeli citizenship.

Why do ethnic groups now self-identified as Palestinian speak the non-indigenous language of Arabic? If thats your mother tongue and you call yourself a Palestinian, your people come originally from colonizers or the colonized. And invaders from practically time immemorial kept carrying my ancestral people away in chains, if they managed to survive massacres. Im glad a maternal great-aunt, and a maternal great-uncle, and my various cousins, survived all the massacres in 1929.

Both Jews and Arabs, and their governing authorities, have been perpetrating atrocities and cruelties upon each other for a very long time.

Want to stop them? Shut the money spigots pouring into the hands of fundamentalist crazies on both sides. They mirror each other in every single way. They have every bad thing in common. I promise you, as one whos been a bat mitzvah girl and an Eid celebrant, Ive got a heck of a mishigas meter.

Want the possibility of peace over there? Neuter the evil twins and let everyone else breathe.

SARAH CRYSL AKHTAR

Lebanon

The rest is here:
Forum, May 28: Elected leaders should follow the science on mask-wearing - Valley News

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

The Wrong Amount of Carbs to Eat Every Day, Says Dietitian – Yahoo Lifestyle

If you are trying to lose weight, manage your blood pressure, or just live a healthy lifestyle, figuring out how many carbs you should eat each day can be easier said than done. One person says to eat carbs all day every day, while another person will imply that this macro is one of the worst things on this earth that you can eat. Which leaves you scratching your head wondering whether eating an apple is going to save your life or if it is going to be the death of you.

Among the sea of advice surrounding how many carbs is ideal, there is one amount that is the wrong amount: zero carbs. As a registered dietitian, I always recommend that zero carbs are the wrong amount of carbs to eat every day, no matter what the diet trends on social media tells you. (Related: 30 Worst Things You Can Do If You're Trying to Lose Weight.)

Carbohydrates, affectionately known as carbs, are what our body uses primarily as fuel and energy. While it is true that the body can break down fat and protein for energy too, leaning on carbs can be a much more efficient way to fuel your body.

Foods that contain carbs are also the best sources of fiber which can help keep your bowel movements healthy, can support a healthy gut microbiome, and can promote satiety after a meal. Not eating enough fiber is linked to some unsavory outcomes, including an increased risk of colon cancer and a higher likelihood of experiencing constipation.

Carbohydrates can also help maintain muscle mass. While it is true that protein is the shining star macro in the muscle-building world, if your body is not getting any carbs, your muscles can be broken down and used as energy.

Read more: 26 Worst Habits Slowing Your Metabolism, Says Science

Even if you are following a diet that is notoriously low in carbs think keto or Atkins, as examples you will be hard-pressed to find a diet that is 100% carb-free. Even hard-core keto allows for some carbs every day, such as low-carb fruits.

Story continues

If you are eliminating carbs completely, you are inevitably eliminating entire food groups. From fruit to whole grains to even milk, eating "no carbs" means that you are essentially living off of protein and fat sources, and thus, missing out on some key nutrients (like fiber).

Eliminating food groups can be risky. As an example, eating fruit is linked to plenty of positive health benefits. From reducing the risk of depression to decreasing the changes of experiencing a heart attack or stroke, including fruit into a diet is utterly important.

Perhaps the most frightening outcome that people may experience when they eat a low amount of carbs (or no carbs) is an elevated risk of experiencing early death along with an elevated risk of developing cancer and experiencing stroke, according to data shared by the European Society of Cardiology.

In a nutshell, completely eliminating carbs from your diet is a risky move.

There are valid reasons why people may follow a low-carb diet, and studies have shown that these diets can provide people with some amazing results. But eating absolutely no carbs is a dangerous game to play. When you completely eliminate carbs from your diet, you are cutting out entire food groups, and therefore may cause you to run the risk of being deficient in some very important nutrients, or worse, cause you to experience some scary health effects.

Instead of eliminating carbohydrates altogether, consider focusing on unrefined carbs that are nutrient-rich and can help support your overall health. From berries to whole grain bread to beans and peas, the healthy carb choices are endless and each one is more satisfying than the next. For some examples, see these 24 Best Healthy Carbs To Eat For Weight Loss.

For more healthy eating news, make sure to sign up for our newsletter!

Read more:
The Wrong Amount of Carbs to Eat Every Day, Says Dietitian - Yahoo Lifestyle

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Pandemic Exacerbates Health Inequities for Individuals with High Blood Pressure – Pharmacy Times

Hypertension and other chronic conditions disproportionately affect people from ethnic and racial minorities, who are often live in under-resourced communities and face historic or systemic disadvantages. Considering these inequities is essential both for COVID-19 responses and for long-term management approaches to chronic conditions.

Media coverage has examined how and why COVID-19 is disproportionately impacting communities of color to some degree, lead author Adam Bress, PharmD, MS, an associate professor of population health science in the division of health system innovation and research at the University of Utah School of Medicine in Salt Lake Sity, said in a statement. However, it is critical that we continue to examine and explain the degree to which the pandemic has widened the divide among race [or] ethnic and class groups in the US and exposed the systemic and institutional cracks in our health care system in terms of health care equity for people who are under-represented and populations that face disadvantages.

A panel of clinicians, investigators, and leaders from diverse backgrounds recently convened to discuss how the COVID-19 pandemic widened inequities in hypertension control and to examine environmental and socioeconomic factors that contribute to disparities within the health care system. They also aimed to develop strategies to help close the gap moving forward.

One large nationwide study of more than 50,000 adults found that the number of individuals maintaining healthy blood pressure (BP) levels had been declining even before the pandemic, and a lack of access to health care and health insurance were major contributing factors. HBP in this study was defined as greater than 140/90 mm Hg, though the American Heart Association guidelines define HBP as greater than 130/80 mm Hg.

This study found that between 2017 and 2018, just 22% of uninsured individuals in the study had healthy BP levels compared with 40% to 46% of those who had some form of health insurance. Furthermore, just 8% of individuals who had not seen a health care professional in the previous year had their BP under control compared with 47% of those who reported seeing a health care professional. The results also suggest that Black adults were 12% less likely to have healthy BP levels than White adults.

The COVID-19 pandemic caused a major shift in health care, with the switch from in-person to virtual medical visits. Although virtual visits can be convenient for many patients, this also presents a challenge, because many individuals do not have access to validated home BP monitors. This lack of access to devices, as well as a lack of internet access or inadequate digital literacy to participate in virtual appointments, posed significant barriers.

Additional obstacles to achieving controlled BP are a lack of adherence to lifestyle changes and medications. Limited trips to grocery stores or physicians offices also resulted in limited access to counseling and healthy food, which can have a negative effect on hypertension.

The panel also noted that distrust of the health care system is a major obstacle to BP control. This distrust is fueled by decades of institutional racism and historical atrocities in medical research, such as the Tuskegee study of syphilis in Black men. To address this distrust, the panel noted that community-based interventions can help foster trust and improve health care access.

One trial illustrating the importance of community interventions was the BARBER trial, in which barbershops in primarily Black neighborhoods in Los Angeles were used to encourage people to meet with pharmacists, who were embedded in the barbershops regularly. The barbershops also promoted healthy lifestyle choices with routine care by physicians.

At 6 months, individuals who participated in the intervention achieved a 21.6 mm Hg greater reduction in systolic BP and had a 51.9% greater increase in BP control than those who did not receive any intervention. These results were sustained at 12 months.

Finally, the panel noted a lack of diversity among investigators, medical school students, and research participants. The results of 1 analysis found that among all hypertension trials registered in the United States, just 5.4% enrolled exclusively Black adults, suggesting that there are few approaches and interventions being specifically studied for this population.

Too often, individuals are blamed for their health care conditions, without considering the multiple levels of social factors and context that contribute to persistent and pervasive health inequities, Bress said.

Health inequities are a social justice issue, she said. We need to be more direct and honest about the reasons for health disparities today and commit to structural solutions to begin to address them.

REFERENCE

COVID-19 pandemic magnified health inequities for people with high blood pressure. News release. American Heart Association. May 19, 2021. Accessed May 21, 2021. https://newsroom.heart.org/news/covid-19-pandemic-magnified-health-inequities-for-people-with-high-blood-pressure?preview=1605

View original post here:
Pandemic Exacerbates Health Inequities for Individuals with High Blood Pressure - Pharmacy Times

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Sizeable Numbers to Endorse Benefits and Efficacy of Umbrella of Hormone Replacement Therapies underscores Growth in Testosterone Replacement Therapy…

ALBANY, N.Y., April 22, 2021 /PRNewswire/ -- Testosterone replacement therapy is widely used treatment for men with symptomatic hypogonadism. The benefits of testosterone replacement therapy manifest as increased energy and libido level, improved bone density and strength, improved muscle strength, and cardioprotective effects. According to The Baltimore Longitudinal Study of Aging, 20% hypogonadism is reported in men over the age of 60 years, 30% in men over 70 years, and 50% in men over 80 years.

Testosterone replacement therapy is a reasonable treatment option often used for men with low testosterone levels and symptoms of hypogonadism. When testosterone is replaced, a number of positive effects of higher testosterone levels are experienced. Thus, the positive results of such therapy has led to a substantial demand for testosterone replacement therapy for men with symptomatic hypogonadism, though there is insufficient data for long-term efficacy and safety of the therapy.

Request for Analysis of COVID-19 Impact on Testosterone Replacement Therapy Market https://www.transparencymarketresearch.com/covid19.php

Nonetheless, the beneficial effects of testosterone replacement therapy is rarely disputed instead widely publicized that marks bright prospects for the testosterone replacement therapy market. As such, in the near-term, from 2019 to 2027, the testosterone replacement therapy market is predicted to rise at a solid 4.4% CAGR.

Testosterone Replacement Therapy Key Findings of the Report

Keen Players seeking Regulatory Approvals for Launch of New Therapies points at Bright Future

Key players in the testosterone replacement therapy market are undertaking efforts to obtain regulatory approvals for launch of new products, integration of novel technologies, and M&As and collaborations with other companies. For example, in the recent past, the U.S. FDA provided approval for a generic testosterone gel to use for testosterone replacement therapy for men with symptomatic hypogonadism. In another example, in March 2019, an oral testosterone capsule produced by Clarus Therapeutics received approval of the U.S. FDA for the treatment of certain forms of hypogonadism.

Request Brochure of Testosterone Replacement Therapy Market Report- https://www.transparencymarketresearch.com/brochure.php

While North America to remain Prominent, Asia Pacific to display Stellar Growth Rate

Factors such as increasing adoption of testosterone replacement therapy and high awareness of availability of convenient treatment options makes North America prominent region in the testosterone replacement therapy market.

On the other hand, Asia Pacific is anticipated to chart an impressive growth rate in the testosterone replacement therapy market in the forthcoming years. Focus of key players to target emerging economies in the region such as India, wherein rising disposable incomes is leading to demand for treatment of unconventional health conditions is creating opportunities in the testosterone replacement therapy market of the region. Besides this, a large population base with testosterone deficiency due to several factors in various countries offers immense prospects for testosterone replacement therapy market of the region.

Purchase the Testosterone Replacement Therapy Market Report- https://www.transparencymarketresearch.com/checkout.php

Solid Marketing Programs to create Awareness Paints Strokes of Growth

Leading players in the testosterone replacement therapy market are undertaking solid marketing programs to promote their branded products, and at the same time create awareness among the general population. Companies in the testosterone replacement therapy market are promoting their products directly to consumers and physicians via journals, meetings, and events.

Testosterone Replacement Therapy Growth Drivers

Request for Custom Research - https://www.transparencymarketresearch.com/custom-research.php

Testosterone Replacement Therapy Key Players

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Continuous Renal Replacement Therapy Market: https://www.transparencymarketresearch.com/continuous-renal-replacement-therapy-market.html

Primary Immunodeficiency Market: https://www.transparencymarketresearch.com/primary-immunodeficiency-disease-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key tohelp enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research:https://www.transparencymarketresearch.com/upcoming.htm

ContactMr. Rohit BhiseyTransparency Market ResearchState Tower,90 State Street,Suite 700,Albany NY - 12207United StatesUSA - Canada Toll Free: 866-552-3453Email: [emailprotected]Press Release Source:https://www.transparencymarketresearch.com/pressrelease/testosterone-replacement-therapy.htmWebsite: https://www.transparencymarketresearch.com/

SOURCE Transparency Market Research

Read the original:
Sizeable Numbers to Endorse Benefits and Efficacy of Umbrella of Hormone Replacement Therapies underscores Growth in Testosterone Replacement Therapy...

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Blue Water Acquisition Corporation Announces Merger Agreement with Clarus Therapeutics, Forming A Publicly Listed Company To Address Unmet Needs Of…

NORTHBROOK, Ill. and GREENWICH, Conn., April 27, 2021 /PRNewswire/ --Clarus TherapeuticsInc. ("Clarus"), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, and Blue Water Acquisition Corp. (NASDAQ: BLUW) ("Blue Water"), a special purpose acquisition company (SPAC), todayannounced adefinitive business combination agreement that will result in Clarus becoming a publicly traded company. This transaction values Clarus at $379 million on a fully diluted basis, assuming no redemptions by Blue Water stockholders. In addition, current Clarus stakeholders will invest an additional $25 million in Clarus following the announcement of this transaction. Subject to stockholder approval and the satisfaction of customary closing conditions, the business combination transaction is expected to close in the third quarter of 2021.

Clarus Therapeutics OverviewClarus was founded by Dr. Robert Dudley, chairman, CEO and president to develop an oral testosterone replacement therapy (TRT) for appropriate men with testosterone deficiency. Dr. Dudley had previously co-invented and launched AndroGel, the most successful TRT product to date, worldwide, but was keenly aware of the need for a safe and effective oral TRT for the approximately 2,000,000 men currently on testosterone therapy in the United States. Of these men, 95% receive topical testosterone gel or weekly testosterone injections. Based on research conducted for Clarus by the Harris organization1, more than 75% of men on non-oral TRT therapies are dissatisfied with their TRT and over 80% are interested in learning about an oral alternative.

In March 2019, Clarus's mission to bring a new, state-of-the-art oral TRT to market was realized with U.S. Food and Drug Administration (FDA) approval of JATENZO (testosterone undecanoate oral capsules; CIII). Prior to JATENZO's approval, the only oral TRT product ever approved by FDA over 60 years ago was one associated with potentially serious liver toxicity a characteristic not observed in clinical studies of JATENZO up to two years in length. Clarus launched JATENZO in February 2020 as the first and only FDA-approved oral softgel for TRT in adult males who have low or no testosterone due to certain medical conditions.2,3,4 JATENZO is available in three softgel strengths so that healthcare professionals can individualize patient testosterone response and adjust dosing, as necessary. Approval of JATENZO addressed a conspicuous void in the TRT market that is currently dominated by topical gels and injections. The funds from these transactions will be invested in growth-driving initiatives for JATENZO and focused R&D to expand the company's pipeline beyond testosterone replacement. Following the close of the transaction, Dr. Dudley will continue to serve as Clarus's CEO and President. Frank Jaeger, Clarus's Chief Commercial Officer, and the architect of AndroGel 1.62%'s sales and marketing efforts that resulted in annual peak sales of over $1 billion, will continue to lead commercialization efforts for JATENZO. Mr. Jaeger has built a team with vast experience in the TRT field.

Investment Highlights

"When I established Clarus, the singular focus of our team was the development and launch of an oral TRT product to address a significant void in treatment options available to appropriate men in need of testosterone therapy. When JATENZO launched in early 2020, it represented not only the culmination of those efforts but also brought our collective vision to life," said Dudley. "Clarus is now ready to enter the public markets and build out its pipeline. The merger with Blue Water Acquisition Corp. is expected to bring fresh capital and exceptional board members to the company so that we can expand our commercialization of JATENZO in the U. S., develop new innovative products, and set a broader course for Clarus beyond men's health."

In addition to monetary value, this transaction brings with it Blue Water's deep expertise in the life sciences and pharmaceutical sectors. We believe this will serve as a complementary asset to Clarus as it expands its footprint in the industry. To this end, Kimberly Murphy, former VP, Global Vaccines Commercialization (Influenza) at GSK will join Clarus's board as Chairperson after close of the transaction.

"We are excited about the prospects for Clarus," said Joseph Hernandez, Chairman and CEO of Blue Water Acquisition Corp. "Clarus's commitment to the success of JATENZO, deep bench of expertise, proclivity for innovation, compelling financial profile and attractive growth prospects are the drivers for our decision to select Clarus as our merger partner after a thorough search. We look forward to working with the impressive team at Clarus to close our merger in a timely manner."

Key Transaction Terms & Proposed Transaction TimelineThis transaction, which has been unanimously approved by the Boards of Directors of Clarus and Blue Water is subject to approval by Clarus's stockholders, Blue Water's stockholders and other customary closing conditions. The proposed business combination is expected to be completed in the third quarter of 2021.

A more detailed description of the transaction terms and a copy of the definitive merger agreement will be included in a Current Report on Form 8-K to be filed by Blue Water with the United States Securities and Exchange Commission ("SEC"). Blue Water will file a registration statement on Form S-4 (which will contain a joint proxy statement/prospectus) with the SEC in connection with the transaction.

AdvisorsTruist Securities acted as a financial advisor and Needham & Company acted as a capital markets advisor to Clarus. Cantor Fitzgerald & Co. and Oppenheimer & Co., Inc. acted as capital markets advisors to Blue Water Acquisition Corp. Maxim Group LLC acted as financial advisor to Blue Water. Goodwin Procter served as legal counsel to Clarus. Ellenoff Grossman & Schole LLP served as legal counsel to Blue Water. Mayer Brown LLP served as legal counsel to the capital markets advisors.

About Clarus Therapeutics, Inc.Clarus is a pharmaceutical company with expertise and interest in developing androgen and metabolic therapies for men and women including potential therapies for orphan indications. Clarus's first commercial product, JATENZO, was launched in early 2020. For more information, visit http://www.clarustherapeutics.com and http://www.jatenzo.com.

About Blue Water Acquisition Corp. Blue Water Acquisition is a special purpose acquisition (SPAC) company incorporated as a Delaware corporation formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Forward-Looking StatementsCertain statements made in this press release are "forward-looking statements" within the meaning of the federal securities laws, including statements about the parties' ability to close the proposed business combination and related transactions, the anticipated benefits of the proposed business combination, and the financial condition, results of operations, earnings outlook and prospects of Blue Water and/or the proposed business combination and related transactions and may include statements for the period following the consummation of the proposed business combination and related transactions. In addition, any statements that refer to projections (financial or otherwise), forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements are typically identified by words such as "plan," "believe," "expect," "anticipate," "intend," "outlook," "estimate," "forecast," "project," "continue," "could," "may," "might," "possible," "potential," "predict," "should," "would" and other similar words and expressions, but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements are based on the current expectations of the management of Blue Water and Clarus Therapeutics, as applicable, and are inherently subject to uncertainties and changes in circumstances and their potential effects and speak only as of the date of such statement. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements including: risks related to Clarus Therapeutics' ability to increase sales of JATENZO, secure favorable reimbursement coverage for such sales and expand its product offerings to include a pipelineof androgen and metabolic therapies for men and women, including orphan indications; the ability to complete the proposed business combination and to obtain approval from Blue Water's stockholders or satisfy other closing conditions in the definitive merger agreement; the outcome of any legal proceedings that may be instituted against Blue Water or Clarus related to the merger agreement or the proposed transaction; the ability to maintain the listing of Blue Water's securities on a national securities exchange; the amount of any redemptions by existing holders of Blue Water's common stock; the ability to recognize the anticipated benefits of the business combination; other risks and uncertainties included under the header "Risk Factors" in the registration statement on Form S-4 to be filed by Blue Water, in the final prospectus of Blue Water for its initial public offering dated December 16, 2020 and in Blue Water's other filings with the SEC.

Additional Information Blue Water has filed today an investor presentation which describes in more detail the proposed transaction and provides a business overview of Clarus Therapeutics. The presentation is available on the U.S. Securities Exchange Commission's (the "SEC") website at http://www.sec.gov.

In connection with the proposed business combination, Blue Water is expected to file a Form S-4 with the SEC. Clarus and Blue Water Acquisition urge investors, stockholders and other interested persons to read, when available, the Form S-4, including the preliminary proxy statement/prospectus and amendments thereto and the definitive proxy statement/final prospectus, as well as other documents to be filed with the SEC in connection with the Transaction, as these materials will contain important information about Clarus Therapeutics, Blue Water, the combined public company and the business combination. Blue Water also will file other documents regarding the Transaction with the SEC. Investors and security holders will be able to obtain free copies of the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by Blue Water through the website maintained by the SEC at http://www.sec.gov.

Participants in the SolicitationBlue Water and its directors and executive officers may be deemed to be participants in the solicitation of proxies from Blue Water's stockholders in connection with the proposed transaction. A list of the names of such directors and executive officers and information regarding their interests in the business combination will be contained in the proxy statement/prospectus when available. You may obtain free copies of these documents as described in the preceding paragraph.

Non-SolicitationThis press release does not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed transaction. This press release also does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities will be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

Media Contact:Russo PartnersDavid Schull12 West 27th Street, 4th FloorNew York, NY10001(858) 717-2310david.schull@russopartnersllc.com

Clarus Investor Relations Contact:Ric PetersonClarus Therapeutics, Inc.555 Skokie Blvd., Suite 340Northbrook, IL 60062(847) 562-4300rpeterson@clarustherapeutics.com

About JATENZO

IndicationJATENZO (testosterone undecanoate) capsules, CIII, is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:

Limitation of useSafety and efficacy of JATENZO in males less than 18 years old have not been established.

IMPORTANT SAFETY INFORMATION

WARNING: INCREASES IN BLOOD PRESSURE

CONTRAINDICATIONSJATENZO is contraindicated in men with breast cancer or known or suspected prostate cancer. JATENZO is contraindicated in women who are pregnant as testosterone may cause fetal harm.

WARNINGS AND PRECAUTIONS

ADVERSE EVENTSThe most common adverse events of JATENZO (incidence 2%) are headache (5%), increased hematocrit (5%), hypertension (4%), decreased HDL (3%), and nausea (2%).

These are not all of the risks associated with JATENZO. For more information, click here for full Prescribing Information, including BOXED WARNING on increases in blood pressure. You can also obtain information regarding Jatenzo at http://www.jatenzo.com.

2021 Clarus Therapeutics, Inc. All rights reserved.

1 Harris Poll conducted online survey between May 6 June 5, 20202 JATENZO (testosterone undecanoate) [prescribing information]. Clarus Therapeutics, Inc.3 US Food & Drug Administration. FDA Approved Drug Products. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206089. Accessed October 1, 2019.4 US Food & Drug Administration. NDA Approval Letter. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/206089Orig1s000ltr.pdf

View original content:http://www.prnewswire.com/news-releases/blue-water-acquisition-corporation-announces-merger-agreement-with-clarus-therapeutics-forming-a-publicly-listed-company-to-address-unmet-needs-of-men-and-women-through-development-of-androgen-and-metabolic-therapies-301277932.html

SOURCE Blue Water Acquisition Corporation; Clarus Therapeutics

Read the original post:
Blue Water Acquisition Corporation Announces Merger Agreement with Clarus Therapeutics, Forming A Publicly Listed Company To Address Unmet Needs Of...

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Testosterone Replacement Therapy Market Size Estimated to Observe Significant Growth by 2024 FLA News – FLA News

TMRs report on the global Testosterone Replacement Therapy market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global Testosterone Replacement Therapy market for the period 20172027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global Testosterone Replacement Therapy market during the forecast period.

Request a PDF Brochure https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1097

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players product literature, annual reports, press releases, and relevant documents to understand the global Testosterone Replacement Therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global Testosterone Replacement Therapy market.

Request a Sample of Testosterone Replacement Therapy Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1097

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global Testosterone Replacement Therapy market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global Testosterone Replacement Therapy market.

The report delves into the competitive landscape of the global Testosterone Replacement Therapy market. Key players operating in the global Testosterone Replacement Therapy market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global Testosterone Replacement Therapy market that have been profiled in this report.

Request for Analysis of COVID19 Impact on Testosterone Replacement Therapy Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1097

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global Testosterone Replacement Therapy market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global Testosterone Replacement Therapy market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMRs study on the Testosterone Replacement Therapy market as primary methods.

Pre-Book Testosterone Replacement Therapy Market Report https://www.transparencymarketresearch.com/checkout.php?rep_id=1097&ltype=S

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the Testosterone Replacement Therapy market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global Testosterone Replacement Therapy market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMRs estimates on future prospects of the global Testosterone Replacement Therapy market more reliably and accurately.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/magnifying-prevalence-of-malnutrition-and-other-disorders-to-add-extra-stars-of-growth-global-medical-foods-market-to-reach-valuation-of-us-33-3-bn-by-2030301123806.html

https://www.prnewswire.com/news-releases/technological-strides-in-ultrasound-devices-market-expand-scope-of-diagnosing-complex-diseases-market-to-clock-cagr-of-5-6-from-2018-to-2026-tmr-301129995.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website:https://www.transparencymarketresearch.com/

Go here to see the original:
Testosterone Replacement Therapy Market Size Estimated to Observe Significant Growth by 2024 FLA News - FLA News

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Elite HRT Releases New Website With Information on Hormone Replacement Therapy – Business Wire

LOS ANGELES--(BUSINESS WIRE)--The physicians at Elite HRT have collaborated on a new website to serve as a one-stop destination for information regarding Hormone Replacement Therapy. This stylish web destination contains numerous articles regarding the potential benefits and detractions involved in various HRT treatments like Human Growth Hormone Therapy (HGH), Testosterone Replacement Therapy (TRT), and Nutraceutical Injections. Elite HRT understands that HRT needs from person to person vary greatly, and hope that this new web design can arm anyone with the information they need to make the right decisions for them.

Elite HRT has worked as on-site and online consultants since 2013, offering medical expertise on innovative new anti-aging and wellness practices. Their treatments are focused on patients goals and individual desires, meaning that no two approaches are exactly the same. To this end they strive to inform their patients as much as possible, equipping them with the knowledge and awareness of all possible hormone therapies so they might know which one is best for them. This information is both cited and sourced to allow patients to do their own research, and to provide transparency so users can understand the science behind these treatments.

Prominently featured on this striking new website are dedicated pages to highlight the different available treatments, so users can compare and contrast each one. These pages focus on HGH injections, Nutraceutical injections, Sermorelin, Testosterone injections, and other low testosterone treatments, highlighting the benefits and potential detractors of each one. Each of these pages is distinct, offering specific nutrients seen in the Nutraceutical treatments and the most prevalent symptoms of low testosterone; this is because each hormone therapy is wholly unique, and taking a one size fits all approach did a disservice to the merits of each individual practice. Elite HRT is pleased with the results, and believe they reflect the diversity of available options.

Online consultations and telemedicine also enable these treatments to be available in rural communities and can help reduce costs by not requiring the use of a dedicated physicians office. As hormone therapies are typically seen as elective and not covered by health insurance plans, Elite HRT works to make these treatments as accessible as possible, including their price. Users can also make use of a local physician for providing physical information and medical history, as part of evaluating the proper treatments for that person.

Elite HRT is proud to offer a one-of-a-kind destination for Hormone Replacement Therapies and all their permutations, so curious users can learn about HGH, TRT, and more from the same destination. With a thorough commitment to providing transparently sourced information and acknowledging the medical professionals who compiled this information, Elite HRT strives to provide information and consultations of the highest quality.

About Elite HRT:

Elite HRT is a telemedicine firm led by a network of physicians specializing in hormone replacement therapies. With unique approaches to HRT, TRT, HGH, and more, Elite HRT works to tailor solutions uniquely created for specific patients, all at affordable rates. Those wanting to learn more and contact Elite HRT can visit https://www.elitehrt.com/ and submit a contact request form with background information today.

Read more:
Elite HRT Releases New Website With Information on Hormone Replacement Therapy - Business Wire

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

New Research: Testosterone Replacement Therapy Market 2026 Industry Specifications and Outlook 2021| Endo International, AbbVie, Eli lilly, Pfizer,…

Global Testosterone Replacement Therapy Industry: with growing significant CAGR during 2021-2026

Trending Testosterone Replacement Therapy Market 2021: COVID-19 Outbreak Impact Analysis

Chicago, United States ,The report entitled Global Testosterone Replacement Therapy Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 released byReport Hive Researchcomprises an assessment of the market which provides the real-time market scenario and its projections during 2021 to 2026 time-period. The report offers an understanding of the demographic changes that took place in recent years. The report presents an analysis of market size, share, growth, trends, statistical and comprehensive facts of the global Testosterone Replacement Therapy market. This research study presents informative information and in-depth evaluation of the market and its segments based totally on technology, geography, region, and applications.

The report highlights several significant features of the global Testosterone Replacement Therapy market encompassing competitive landscape, segmentation analysis, and industry environment. It shows the scope of the market and a brief overview of the definition and description of the product or service. The potential factors that can bring the market to the upward direction have been mentioned in the report. With this report, companies, as well as individuals interested in this report, will get proven valuable guidelines and direction so that they consolidate their position in the market.

The major players and the new entrants have been incorporating strategic merger and acquisition activities amongst each other to testify the factors responsible for changing dynamics. These changing dynamics implore the players to keep up with rising demands or present restrains so as to drive the broad scope of the global Testosterone Replacement Therapy Market.

>>>>The study encompasses profiles of major companies operating in the global Testosterone Replacement Therapy Market. Key players profiled in the report include: Endo International, AbbVie, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals

Analysis of Global Testosterone Replacement Therapy Market By Type: GelsInjectionsPatchesOthers

Analysis of Global Testosterone Replacement Therapy Market By Application: HospitalsClinicsOthers

Drivers And Risks:The report covers the basic dynamics of the global Testosterone Replacement Therapy market. It scrutinizes several data and figures, and numerous volume trends. A number of potential growth factors, risks, restraints, challenges, market developments, opportunities, strengths, and weaknesses have been highlighted. Another factor affecting market growth has also been included in the report.

Regional Analysis:The report comprises of regional development status, covering all the major regions of the world. This regional status shows the size (in terms of value and volume), and price data for the global Testosterone Replacement Therapy market. The development of the industry is assessed with information on the current status of the industry in various regions. Data type assessed concerning various regions includes capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export, etc.

Report offers:

>>>>Get Full Customize report @ https://www.reporthive.com/request_customization/2507819

Regional coverage:North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

NOTE: Our team is studying Covid-19 impact analysis on various industry verticals and Country Level impact for a better analysis of markets and industries. The 2021 latest edition of this report is entitled to provide additional commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation.

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Testosterone Replacement Therapy market.

Chapter 2: Evaluating the leading manufacturers of the global Testosterone Replacement Therapy market which consists of its revenue, sales, and price of the products.

Chapter 3: the competitive nature among key manufacturers, with market share, revenue, and sales.

Chapter 4: Presenting global Testosterone Replacement Therapy market by regions, market share and revenue and sales for the projected period.

Chapters 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Profiling Key players: Endo International, AbbVie, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals

In this report, Leading players of the global Testosterone Replacement Therapy Market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Testosterone Replacement Therapy Market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Testosterone Replacement Therapy Market. It also provides useful recommendations for new as well as established players of the global Testosterone Replacement Therapy Market.

Get Free Sample Copy of this report: https://www.reporthive.com/request_sample/2507819

Testosterone Replacement Therapy Market CAGR Competitive Landscape, Market Research, Testosterone Replacement Therapy Market Best Companies in The world , Testosterone Replacement Therapy Market Top Companies in The world, Testosterone Replacement Therapy Market Trend, Testosterone Replacement Therapy Trends, Testosterone Replacement Therapy growth, Testosterone Replacement Therapy industry, Testosterone Replacement Therapy Covid-19 Impact Analysis

Why Go For Report Hive Research?

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Get in Touch with Us :Report Hive Research500, North Michigan Avenue,Suite 6014,Chicago, IL 60611,United StatesPhone:+1 312-604-7084

View original post here:
New Research: Testosterone Replacement Therapy Market 2026 Industry Specifications and Outlook 2021| Endo International, AbbVie, Eli lilly, Pfizer,...

Recommendation and review posted by Alexandra Lee Anderson

Read the Rest...

Page 4«..3456..1020..»